We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian generic drug manufacturer Dr. Reddy’s Laboratories has signed a deal to acquire Germany’s Betapharm Arzeniemittel GmbH for roughly $570 million.